Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
18 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/transcenta-updates-encouraging-efficacy-data-from-first-line-triple-combo-trial-of-osemitamab-tst001-for-ggej-cancer-at-esmo-2024-302251645.html
29 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/transcenta-holding-limited-stock-code-6628hk-announce-2024-interim-results-302233808.html
09 Apr 2024
// PHARMABIZ
08 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/transcenta-announces-collaboration-with-agilent-to-develop-a-claudin18-2-companion-diagnostic-to-support-osemitamab-tst001-global-phase-iii-trial-302111036.html
13 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/transcenta-announces-the-publication-of-preclinical-results-of-177lulu-tst001-radionuclide-antibody-conjugate-as-potential-novel-treatment-option-for-metastatic-gastric-cancer-in-the-european-journal-of-nuclear-medicine-and-mole-302013860.html
23 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/transcenta-unveils-updated-efficacy-data-from-osemitamab-tst001-plus-capox-as-first-line-treatment-for-ggej-cancer-study-at-esmo-2023-301964563.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?